CSIMarket
 


Travere Therapeutics Inc   (TVTX)
Other Ticker:  
 
 

TVTX's Revenue Growth by Quarter and Year

Travere Therapeutics Inc 's Revenue results by quarter and year




TVTX Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 57.25 51.14 44.37
III Quarter September 53.50 68.22 48.43 44.71
II Quarter June 54.17 54.62 47.77 39.57
I Quarter March 48.49 47.41 46.69 43.77
FY   156.16 227.50 194.03 172.42



TVTX Revenue third quarter 2022 Y/Y Growth Comment
Travere Therapeutics Inc reported decline in Revenue in the third quarter 2022 by -21.58% to $ 53.50 millions, from the same quarter in 2021.
The contraction in the third quarter 2022 Travere Therapeutics Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.41%.

Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Revenue growth. While Travere Therapeutics Inc ' s Revenue fall of -21.58% ranks overall at the positon no. 511 in the third quarter 2022.




TVTX Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 11.95 % 15.26 % 8.99 %
III Quarter September -21.58 % 40.86 % 8.32 % 8.15 %
II Quarter June -0.82 % 14.34 % 20.72 % 2.97 %
I Quarter March 2.28 % 1.54 % 6.67 % -6.93 %
FY   - 17.25 % 12.53 % 2.93 %

Financial Statements
Travere Therapeutics Inc 's third quarter 2022 Revenue $ 53.50 millions TVTX's Income Statement
Travere Therapeutics Inc 's third quarter 2021 Revenue $ 68.22 millions Quarterly TVTX's Income Statement
New: More TVTX's historic Revenue Growth >>


TVTX Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -16.08 % 5.6 % -0.76 %
III Quarter September -1.24 % 24.9 % 1.38 % 12.99 %
II Quarter June 11.71 % 15.21 % 2.31 % -9.6 %
I Quarter March -15.3 % -7.29 % 5.23 % 7.52 %
FY (Year on Year)   - 17.25 % 12.53 % 2.93 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #45
Overall #511

Revenue Y/Y Growth Statistics
High Average Low
19.59 % 3.41 % -6.45 %
(Dec. 30, 2015)   (Sep 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #45
Overall #511
Revenue Y/Y Growth Statistics
High Average Low
19.59 % 3.41 % -6.45 %
(Dec. 30, 2015)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Travere Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20479.69 % 691.37 % -18.29 %
(Jun 30 2014)  


TVTX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Travere Therapeutics Inc disclosed decrease in Revenue from the second quarter by -1.24% to $ 53.50 millions, from $ 54.17 millions achived in the previous quarter.

Albeit cyclical influence usually energize III. Quarter 2022 performance, this plainly could not be enough to recover Major Pharmaceutical Preparations's company achievement, Victoria Edwards, Major Pharmaceutical Preparations industry consultant allocated in Chicago pointed out and wrote that average quarter on quarter Revenue growth is at 691.37% for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Travere Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 349.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #26
Overall #349
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #26
Overall #349
Revenue Q/Q Growth Statistics
High Average Low
20479.69 % 691.37 % -18.29 %
(Jun 30 2014)  


TVTX's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Travere Therapeutics Inc reported decrease in Revenue from the previous quarter by -1.24% to $ 53.50 millions, from $ 54.17 millions achived in the previous quarter.

Some periodic factors which usually fuel III. Quarter 2022 results, have not rescue the III. Quarter for the Travere Therapeutics Inc , Victoria Edwards, Major Pharmaceutical Preparations industry consultant allocated in Chicago said, she cited little caution towards TVTX's direction, she identified new difficulties down the road for TVTX.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Travere Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 349.


Travere Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 213.40 $ 228.12 $ 228.57 $ 227.49 $ 221.38
Y / Y Revenue Growth (TTM) -3.61 % 13.16 % 17.37 % 17.25 % 18.22 %
Year on Year Revenue Growth Overall Ranking # 461 # 1536 # 1420 # 858 # 445
Seqeuential Revenue Change (TTM) -6.45 % -0.2 % 0.47 % 2.76 % 9.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 511 # 2919 # 2226 # 1055 # 198




Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2022 Travere Therapeutics Inc reported a decrease in Revenue by -3.61% year on year, to $213 millions, compare to the 13.16% growth at Jun 30 2022.

In the Healthcare sector 41 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 461, from total ranking in previous quarter at 1536.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.59 %
3.41 %
-6.45 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 42
Overall # 461

Revenue TTM Y/Y Growth Statistics
High Average Low
254.19 %
26.57 %
-3.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 45
S&P 500 # 511
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2022 Travere Therapeutics Inc reported a decrease in Revenue by -3.61% year on year, to $213 millions, compare to the 13.16% growth at Jun 30 2022.

In the Healthcare sector 41 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 461, from total ranking in previous quarter at 1536.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.59 %
3.41 %
-6.45 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 42
Overall # 461

Revenue TTM Y/Y Growth Statistics
High Average Low
254.19 %
26.57 %
-3.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 45
S&P 500 # 511




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TVTX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TVTX's Competitors
Revenue Growth for Travere Therapeutics Inc 's Suppliers
Revenue Growth for TVTX's Customers

You may also want to know
TVTX's Annual Growth Rates TVTX's Profitability Ratios TVTX's Asset Turnover Ratio TVTX's Dividend Growth
TVTX's Roe TVTX's Valuation Ratios TVTX's Financial Strength Ratios TVTX's Dividend Payout Ratio
TVTX's Roa TVTX's Inventory Turnover Ratio TVTX's Growth Rates TVTX's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPRT's Profile

Stock Price

CPRT's Financials

Business Description

Fundamentals

Charts & Quotes

CPRT's News

Suppliers

CPRT's Competitors

Customers & Markets

Economic Indicators

CPRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071